Non-invasive brain stimulation for motivation issues in Parkinson's Disease
Official title: Investigation of Non-invasive Brain Stimulation for the Treatment of Apathy
Run by University of North Carolina, Chapel Hill · NCT06087926 · Data updated 2026-11-12
This study is testing if a type of brain stimulation can help reduce feelings of apathy in people with Parkinson's Disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT06087926 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with idiopathic Parkinson Disease who have experienced symptoms for at least five years and are stable on dopaminergic medication.
✕Probably not a fit
Patients with severe cognitive impairment, such as dementia, or those unable to perform the required tasks may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to explore the effects of transcranial magnetic stimulation (TMS) on apathy in patients with Parkinson's Disease. Participants will undergo a series of assessments, including questionnaires and effort tasks, while their brain activity is monitored using EEG. The study will compare the effects of TMS applied to two different brain locations to determine if one site can effectively reduce apathy. Each participant will attend three visits, with the first focused on assessments and the subsequent visits dedicated to TMS and task performance.
Why it matters
Potential benefit: If successful, this study could lead to new non-invasive treatment options for improving motivation in Parkinson's Disease patients.
How similar studies have gone: While the approach of using TMS for apathy in Parkinson's Disease is relatively novel, similar studies have shown promise in using brain stimulation techniques for various neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of idiopathic Parkinson Disease. * At least 4 years of symptoms. * On dopaminergic medication for Parkinson Disease. * Stable on dopaminergic medication and other medications which may influence apathy (such as selective serotonin re-uptake inhibitors, stimulant medications) for at least 4 weeks prior to first study visit and remain stable throughout the study period. * Hospital's study-specific informed consent must be obtained. * Must have capacity to provide informed consent in English. * For female participants, confirmation that they have not had a menstrual period in over 12 months, or that they will use an effective form of contraception during the study. Exclusion Criteria: * Inability to provide informed consent. * Inability to perform effort task (determined during the titration session). * Presence of dementia (Montreal Cognitive Assessment (MoCA) score \< 21). * History of epilepsy or brain surgery. * Severe tremor or dyskinesia that would interfere with EEG (determined by the PI). * Patients with clinically significant medical or neurological conditions which may be an alternative cause of parkinsonism such as repeated brain injury, anti-dopaminergic medications, anoxic brain injury, or significant basal ganglia strokes. * Presence of other known central nervous system disease that may interfere with performance or interpretation of EEG or TMS. * Presence of any implanted metal devices including, but not limited to, pacemakers, deep brain stimulators, vagal nerve stimulators, bladder stimulators, or cochlear implants. * Presence of medical contraindications to TMS such as implanted stimulators, history of mania or bipolar disorder, history of epilepsy.
Where it's running
-
UNC-Chapel Hill, Cassidy Lab
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Miriam Sklerov, MD — University of North Carolina, Chapel Hill
- Study coordinator: Cole Shumate
- Email: shumatec@neurology.unc.edu
- Phone: 919-445-0979
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.